Ambu A/S header image

Ambu A/S

AMBU B

Equity

ISIN DK0060946788 / Valor 39639588

Nasdaq Copenhagen Equities (2026-02-20)
DKK 81.45+1.69%

Ambu A/S
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ambu A/S is a Danish multinational medical technology company specializing in the development, manufacturing, and distribution of single-use endoscopy solutions, as well as products for anesthesia and patient monitoring. The company is recognized as a market leader in single-use endoscopy, offering a comprehensive portfolio that covers pulmonology, urology, ear-nose-throat (ENT), and gastroenterology (GI). Ambu's endoscopes are designed to operate on a unified platform, providing healthcare professionals with an interconnected system that enhances workflow efficiency and patient care. In addition to its endoscopy solutions, Ambu maintains a strong presence in the fields of anesthesia and patient monitoring, with a legacy that includes the invention of the first self-inflating resuscitator, known as the "Ambu bag," in 1956. The company operates globally, with production facilities in the USA, China, Malaysia, and Mexico, and serves over 100 million patients worldwide. Ambu's commitment to innovation and quality continues to drive its mission to support healthcare professionals in saving lives and improving patient outcomes.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-42.5%1Y
-22.3%3Y
-72.8%5Y

Performance

37.8%1Y
40.5%3Y
50.0%5Y

Volatility

Market cap

2978 M

Market cap (USD)

Daily traded volume (Shares)

878,847

Daily traded volume (Shares)

1 day high/low

107.55 / 106.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Viking Therapeutics Inc
Viking Therapeutics Inc Viking Therapeutics Inc Valor: 24839858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%USD 31.03
CureVac N.V.
CureVac N.V. CureVac N.V. Valor: 56537572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 4.66
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. Nano-X Imaging Ltd. Valor: 56410599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.67%USD 2.43
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.77%USD 2.45
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 2.27
Stride Inc
Stride Inc Stride Inc Valor: 58406765
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%USD 82.58
Biohaven Research Ltd
Biohaven Research Ltd Biohaven Research Ltd Valor: 121902526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.40%USD 11.23
Cooper Companies Inc
Cooper Companies Inc Cooper Companies Inc Valor: 132951296
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%USD 84.07
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc Amneal Pharmaceuticals Inc Valor: 41368351
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%USD 14.50
Waystar Holding Corp
Waystar Holding Corp Waystar Holding Corp Valor: 130358792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.79%USD 25.07